FDA clears AI-based algorithm to detect heart failure during physical exam
Key takeaways:
- An AI-based algorithm for the detection of heart failure gained FDA clearance.
- The system is designed to quickly detect low ejection fraction during a routine physical exam.
Eko Health announced it received FDA clearance for its artificial intelligence algorithm for the detection of heart failure during routine physical exams.
Developed in partnership with Mayo Clinic to be used with the company’s cardiac early detection platform (Sensora) and digital stethoscope (Eko), the AI-based algorithm (Eko Low EF AI) is designed to detect low ejection fraction in 15 seconds during a primary care exam, according to a company press release.
“The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with — the stethoscope — can help us prevent hospitalizations and adverse events,” Paul Friedman, MD, chair of the department of cardiovascular medicine at Mayo Clinic, said in the release. “Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.”
Collapse